Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Change in Intangibles: 2023-2024

Historic Change in Intangibles for Mereo BioPharma Group (MREO) over the last 2 years, with Dec 2024 value amounting to $699,000.

  • Mereo BioPharma Group's Change in Intangibles fell 57.14% to $300,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $699,000 for FY2024, which is 66.83% up from last year.
  • Latest data reveals that Mereo BioPharma Group reported Change in Intangibles of $699,000 as of FY2024, which was up 66.83% from $419,000 recorded in FY2023.
  • In the past 5 years, Mereo BioPharma Group's Change in Intangibles registered a high of $699,000 during FY2024, and its lowest value of $419,000 during FY2023.
  • Moreover, its 2-year median value for Change in Intangibles was $559,000 (2023), whereas its average is $559,000.
  • Data for Mereo BioPharma Group's Change in Intangibles shows a peak YoY skyrocketed of 66.83% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Mereo BioPharma Group's Change in Intangibles stood at $419,000 in 2023, then spiked by 66.83% to $699,000 in 2024.